Risk factor profile for chronic kidney disease is similar to risk factor profile for small artery disease

Journal of Hypertension

Volumn 29, Issue 9, 2011, Pages 1796-1801

  Turner, Stephen T ^a,c   Rule, Andrew D ^a,c   Schwartz, Gary L ^a,c   Kullo, Iftikhar J ^b,c   Mosley, Thomas H ^d   Jack, Clifford R ^c   Kardia, Sharon L R ^e   Boerwinkle, Eric ^f   Bailey, Kent R ^a  

^a MAYO CLINIC   (United States)

^b Division of Cardiovascular Diseases   (United States)

^c Department of Internal Medicine ^*  (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

albuminuria; ankle brachial blood pressure index; arteriosclerosis; blood pressure; glomerular filtration rate; hypertension; subcortical white matter hyperintensity

Indexed keywords

CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BRAIN ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING; WHITE MATTER;

EID: 80051932734     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328349052b     Document Type: Article

References (44)

1. Kumar V, Abbas AK, Fausto N, Robbins SL, Cotran RS. Robbins and Cotran pathologic basis of disease. Philadelphia: Elsevier Saunders; 2005.
2. O'Rourke MF. Link between macrocirculation and microcirculation in isolated systolic hypertension of older subjects. Am J Hypertens 2009; 22:469.
3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
4. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997; 28:652-659. (Pubitemid 27118393)
5. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300:197-208. (Pubitemid 351969304)
6. Chrysochou C, Kalra PA. Epidemiology and natural history of atherosclerotic renovascular disease. Prog Cardiovasc Dis 2009; 52:184-195.
7. Tracy RE. The role of aging in atherosclerosis: the sequestration hypothesis. Dordrecht; Boston: Kluwer Academic Publishers; 2003.
8. Daniels PR, Kardia SL, Hanis CL, Brown CA, Hutchinson R, Boerwinkle E, Turner ST. Familial aggregation of hypertension treatment and control in the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Am J Med 2004; 116:676-681. (Pubitemid 38581113)
9. The FBPP Investigators. Multicenter genetic study of hypertension: the family blood pressure program (fbpp). Hypertension 2002; 39:3-9.
10. Melton LJ 3rd. History of the Rochester epidemiology project. Mayo Clin Proc 1996; 71:266-274.
11. The ARIC investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 1989; 129:687-702.
12. Turner ST, Fornage M, Jack CR Jr, Mosley TH, Knopman DS, Kardia SL, et al. Genomic susceptibility loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships. Arch Neurol 2009; 66:847-857.
13. Kullo IJ, Bailey KR, Kardia SL, Mosley TH Jr, Boerwinkle E, Turner ST. Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med 2003; 8:237-242. (Pubitemid 38585137)
14. O'Meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med 2004; 164:1313-1318. (Pubitemid 38828882)
15. Freedman BI, Beck SR, Rich SS, Heiss G, Lewis CE, Turner S, et al. A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension 2003; 42:291-296. (Pubitemid 37093475)
16. Levey AS, Stevens LA, Schmid CH, Zhang YL,Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
17. Jack CR Jr, O'Brien PC, Rettman DW, Shiung MM, Xu Y, Muthupillai R, et al. Flair histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging 2001; 14:668-676. (Pubitemid 33101524)
18. Rule AD, Bailey KR, Schwartz GL, Khosla S, Lieske JC, Melton LJ 3rd. For estimating creatinine clearance measuring muscle mass gives better results than those based on demographics. Kidney Int 2009; 75:1071-1078.
19. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 2008; 117:743-753. (Pubitemid 351640675)
20. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004; 351:1344-1346. (Pubitemid 39258430)
21. Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, et al. Excerpts from the US renal data system 2009 annual data report. Am J Kidney Dis 2010; 55:S1-S420.
22. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult us population: third national health and nutrition examination survey. Am J Kidney Dis 2003; 41:1-12. (Pubitemid 36043346)
23. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23 534 men and women in Washington county, Maryland. J Am Soc Nephrol 2003; 14:2934-2941. (Pubitemid 37305656)
24. McClellan WM, Langston RD, Presley R. Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease. J Am Soc Nephrol 2004; 15:1912-1919. (Pubitemid 38822072)
25. Jee SH, Boulware LE, Guallar E, Suh I, Appel LJ, Miller ER 3rd. Direct, progressive association of cardiovascular risk factors with incident proteinuria: results from the Korea Medical Insurance Corporation (KMIC) study. Arch Intern Med 2005; 165:2299-2304. (Pubitemid 41549928)
26. Fogo A, Breyer J, Smith M, Cleveland W, Agodoa L, Kirk K, Glassock R. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) trial. Kidney Int 1997; 51:244-252. (Pubitemid 27064543)
27. Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 1987; 31:1153-1159. (Pubitemid 17069099)
28. Tracy RE, Strong JP, Newman WP 3rd, Malcom GT, Oalmann MC, Guzman MA. Renovasculopathies of nephrosclerosis in relation to atherosclerosis at ages 25 to 54 years. Kidney Int 1996; 49:564-570. (Pubitemid 26050332)
29. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA. Chronic kidney disease and cardiovascular disease in the medicare population. Kidney Int Suppl 2003; 49:S24-S31. (Pubitemid 37315504)
30. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351:1285-1295. (Pubitemid 39258422)
31. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
32. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004; 291:210-215. (Pubitemid 38082815)
33. Chambless LE, Folsom AR, Sharrett AR, Sorlie P, Couper D, Szklo M, Nieto FJ. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol 2003; 56:880-890. (Pubitemid 37162663)
34. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam scan study. Stroke 2003; 34:1126-1129. (Pubitemid 36547501)
35. Kuller LH, Longstreth WT Jr, Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004; 35:1821-1825. (Pubitemid 38971858)
36. Criqui MH, Browner D, Fronek A, Klauber MR, Coughlin SS, Barrett-Connor E, Gabriel SAM. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease: an analysis of risk factors. Am J Epidemiol 1989; 129:1110-1119. (Pubitemid 19148454)
37. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the cardiovascular health study. Arch Neurol 1998; 55:1217-1225.
38. DeBakey ME, Glaeser DH. Patterns of atherosclerosis: effect of risk factors on recurrence and survival-analysis of 11 890 cases with more than 25-year follow-up. Am J Cardiol 2000; 85:1045-1053. (Pubitemid 30214247)
39. Stuveling EM, Hillege HL, Bakker SJ, Asselbergs FW, de Jong PE, Gans RO, de Zeeuw D. C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. Atherosclerosis 2004; 172:107-114. (Pubitemid 38058607)
40. Strain WD, Chaturvedi N, Leggetter S, Nihoyannopoulos P, Rajkumar C, Bulpitt CJ, Shore AC. Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. J Hypertens 2005; 23:133-140. (Pubitemid 40128991)
41. Pepine CJ, Kerensky RA, Lambert CR, Smith KM, von Mering GO, Sopko G, Bairey Merz CN. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol 2006; 47:S30-S35.
42. CarnethonMR, Lynch EB, Dyer AR, Lloyd-Jones DM, Wang R, Garside DB, Greenland P. Comparison of risk factors for cardiovascular mortality in black and white adults. Arch Intern Med 2006; 166:1196-1202. (Pubitemid 43877628)
43. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-2047. (Pubitemid 350074801)
44. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349:1269-1276. (Pubitemid 27192468)